Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
08/2008
08/13/2008EP1954824A1 Dog diabetes
08/13/2008EP1954692A1 Heterocycle-substituted 3-alkyl azetidine derivatives
08/13/2008EP1954673A1 Hydroxy-substituted diphenylazetidinones for the treatment of hyperlipidaemia
08/13/2008EP1954314A2 Preparation, comprising iron(iii) complex compounds and redox-active substances
08/13/2008EP1954313A1 Treatment of obesity and related disorders
08/13/2008EP1954299A1 Use of a protein hydrolysate for enhancing activity of glucagon-like peptide-1
08/13/2008EP1866280B1 Acyl hydrazides as kinase inhibitors, in particular for sgk
08/13/2008EP1828177B1 Novel mch receptor antagonists
08/13/2008EP1572196B1 Combination of a dpp-iv inhibitor and a ppar-alpha compound
08/13/2008EP1501803B1 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
08/13/2008EP1501566B1 Medical products comprising a haemocompatible coating, production and use thereof
08/13/2008EP1497263B1 Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
08/13/2008EP1494673B1 Compounds having unique cb1 receptor binding selectivity and methods for their production and use
08/13/2008EP1489088B1 Novel alpha-amino-n-(diaminophosphinyl)lactam derivative
08/13/2008EP1467979B1 Fused heterocyclic compounds and analogs thereof modulators of nuclear hormone receptor function
08/13/2008EP1463801B1 Transdifferentiation of pancreatic acinar cells
08/13/2008EP1453501B1 N- aryl-n'-arylcycloalkyl-urea derivatives as mch antagonists for the treatment of obesity
08/13/2008EP1452528B1 Xanthine oxidase inhibitors
08/13/2008EP1359931A4 Prevention of diabetes by administration of gnrh antagonists
08/13/2008EP1322309B1 High affinity small molecule c5a receptor modulators
08/13/2008EP1200117B1 Lipoprotein lipase (lpl) variant therapeutics
08/13/2008EP1137773B1 Growth factor homolog zvegf3
08/13/2008EP1082029B1 Sitostanol formulation with emulsifier to reduce cholesterol absorption
08/13/2008EP0936913B1 Oral pharmaceutical preparation containing ibandronat
08/13/2008CN101243081A Pyrido[2,3-d]pyrimidine-2,4-diamine compounds as PTP1B inhibitors
08/13/2008CN101243078A Thiazolyl piperidine derivatives useful as h3 receptor modulators
08/13/2008CN101243076A Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
08/13/2008CN101243074A Heterocyclic compounds
08/13/2008CN101243072A Piperidine derivatives useful as histamine H3 antagonists
08/13/2008CN101243058A Oxadiazole derivatives as DGAT inhibitors
08/13/2008CN101243056A Crystal of phenylalanine derivative, process for producing the same and use thereof
08/13/2008CN101243053A N-acylic aminoacid derivatives, method for the production thereof, pharmacological composition and the use in the form of anti-allergic, anti-inflammatory and hypolipidemic agents
08/13/2008CN101243047A Phenoxy acetic acids as PPAR delta activators
08/13/2008CN101243045A New 2-azetidinone derivatives for the treatment of hyperlipidaemic diseases
08/13/2008CN101243044A Novel 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions
08/13/2008CN101242858A Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
08/13/2008CN101242833A Pyrrolopyridine derivatives and use of same as PPAR receptor modulators
08/13/2008CN101242748A Infant nutrition with protease inhibitor
08/13/2008CN101241127A Sgk and Nedd used as diagnostic and therapeutic targets
08/13/2008CN101240262A Islet cells from human embryonic stem cells
08/13/2008CN101240037A Jelly fungi heptasaccharide and its preparation technique and application
08/13/2008CN101240033A Fusion protein of insulin secretion accelerating peptide and human serum albumin, and preparation method thereof
08/13/2008CN101240000A Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
08/13/2008CN101239928A Propanoic derivatives for treating lipid metabolism disorder
08/13/2008CN101239925A Method for preparing magnesium aspartate
08/13/2008CN101239153A Medicament for treating diabetes
08/13/2008CN101239149A Orally-taken Chinese medicinal composition for treating diabetes
08/13/2008CN101239147A Special-purpose medicaments for treating diabetes and complication thereof
08/13/2008CN101239112A Chinese medicinal composition for regulating blood fat and preparation thereof
08/13/2008CN101239090A Pharmaceutical compositions having appetite suppressant activity
08/13/2008CN101239089A Pharmaceutical compositions having appetite suppressant activity
08/13/2008CN101239082A Preparation of buckeye total saponins and its anti-obesity function
08/13/2008CN101239073A Composite preparations for preventing and treating type II diabetes
08/13/2008CN101239047A Composition for releasing a weak base for an extended period of time
08/13/2008CN101239046A Epalrestat dropping pills and preparation thereof
08/13/2008CN101239045A Atorvastatin dropping pills and preparation thereof
08/13/2008CN101238909A Chickpea bean sprout juice and preparation method and application
08/13/2008CN101238869A Low sugar grain special for diabetes
08/13/2008CN101238845A Donkey-hide gelatin motherwort brown sugar
08/13/2008CN100410661C Quality control method of heat-clearing toxin-removing cold-treating honeysuckle injection
08/13/2008CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases
08/13/2008CN100410248C Modifications of the trometamol salt of R-thioctic acid as well as a process for their production
08/13/2008CN100410236C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps)
08/13/2008CN100409855C Tablet containing lucid ganoderma and spirulina spp., and its preparation method
08/13/2008CN100409845C Association and medicinal composition of CB1 receptor antagonist and application in preparing medicament for treating obesity
08/13/2008CN100409757C Preparing method of fat-regulating blood-pressure stabilizing health-care tea
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7411055 Genetic engineering
08/12/2008US7411041 DCRS5 polypeptides
08/12/2008US7410990 Heterocyclic compounds
08/12/2008US7410984 novel pyridone derivatives capable of inhibiting alpha 4 integrin mediated cell adhesion; to treat chronic inflammatory diseases; 3-(4-{2-Oxo-3-[4-(3-o-tolyl-ureido)phenyl]-2H-pyridin-1-ylmethyl}phenyl)propionic acid; hydrolysis
08/12/2008US7410983 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction
08/12/2008US7410959 To treat obesity or diabetes; reduction of serum cholesterol and the treatment of atherosclerosis
08/12/2008US7410955 Therapeutic use of agonist ligands specific to G2A receptor
08/12/2008US7410946 Method for treating damage in intact skin comprising administering a composition comprising basic milk growth factors in amounts higher than those in milk
08/12/2008US7410799 In vivo production and delivery of erythropoietin or insulinotropin for gene therapy
08/12/2008US7410652 Controlled release and taste masking oral pharmaceutical composition
08/12/2008US7410651 Controlled release and taste masking oral pharmaceutical composition
08/12/2008US7410642 Assays and therapies for latent viral infection
08/12/2008US7410641 Hybridoma and monoclonal antibodies produced; insulin-like growth factor (IGF); diagnosis, treatment, prevention of diabetes and metabolic disorders
08/12/2008US7410616 Device for the controlled exposure of reservoir-based sensors
08/12/2008CA2376236C Modification of biological elements
08/12/2008CA2359819C 2-oxy-benzoxazinone derivatives for the treatment of obesity
08/12/2008CA2217551C Photoactivated hypericin and the use thereof
08/07/2008WO2008095189A1 Methods and compositions for treating dyslipidaemia
08/07/2008WO2008094939A1 Use of chromium histidinate for treatment of cardiometabolic disorders
08/07/2008WO2008094909A2 Quinazolinone and fused pyrimidinone compounds and their use in treating sodium channel-mediated diseases or conditions
08/07/2008WO2008094905A2 Encapsulated hdl mimetic peptides
08/07/2008WO2008094869A1 Soluble epoxide hydrolase inhibitors for treatment of metabolic syndrome and related disorders
08/07/2008WO2008094473A1 Substituted pyrano[2,3-b]pyridine derivatives as cannabinoid-1 receptor modulators
08/07/2008WO2008094222A2 Porphyrin catalysts and methods of use thereof
08/07/2008WO2008093951A1 Atorvastatin strontium salt and pharmaceutical composition comprising same
08/07/2008WO2008093848A1 Composition for decreasing inflammation marker comprising phosphatidylcholine
08/07/2008WO2008093826A1 Adiponectin-increasing agent
08/07/2008WO2008093764A1 Composition for prevention or treatment of diabetes
08/07/2008WO2008093737A1 Amide derivative
08/07/2008WO2008093670A1 Fermentation product of grape skin/seed by lactic acid bacteria, and pharmaceutical agent and food utilizing the same
08/07/2008WO2008093655A1 Polyalcohol compound and pharmaceutical agent
08/07/2008WO2008093646A1 Peptide capable of activating wnt signaling
08/07/2008WO2008093639A1 Pyrazole compound
1 ... 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 ... 1298